MedTrace Logo

Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children

NCT02128984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2019-07-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether a nutritional supplement is effective in the treatment of malnutrition in pediatric patients with failure to thrive or cystic fibrosis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Symbiotic Formula with DHA and antioxidants

6 months intervention.

DIETARY_SUPPLEMENT

Standard Formula

6 months intervention.

Sponsors & Collaborators

  • Quantum Experimental

    collaborator UNKNOWN

  • Peruvian Clinical Research

    collaborator OTHER

  • Laboratorios Ordesa

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2015-02-28
Completion
2015-05-31

Countries

  • Peru
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128984 on ClinicalTrials.gov